-+ 0.00%
-+ 0.00%
-+ 0.00%

LIRUM THERAPEUTICS ANNOUNCES FDA "STUDY MAY PROCEED" LETTER ENABLING INCLUSION OF LX-101 IN RAPID PLATFORM CLINICAL TRIAL FOR EWING SARCOMA AND DESMOPLASTIC SMALL ROUND CELL TUMOR

Reuters·10/20/2025 20:20:55

Please log in to view news